Pharmacological Intensification Strategies in Highly Refractory Obsessive–Compulsive Disorder: Evidence Synthesis and a Tertiary-Care Case Series
Mario Pinzi, Alessandro Cuomo, Pietro Carmellini, Claudia Libri, Maria B. Rescalli, Caterina Pierini, Alessia Santangelo, Benjamin Patrizio, Andrea Fagiolini · 2026
Read Pharmacological Intensification Strategies in Highly Refractory Obsessive–Compulsive Disorder: Evidence Synthesis and a Tertiary-Care Case Series by Mario Pinzi, Alessandro Cuomo, Pietro Carmellini, Claudia Libri, Maria B. Rescalli, Caterina Pierini, Alessia Santangelo, Benjamin Patrizio, Andrea Fagiolini (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13302481.txt.
Description
When standard drugs fail stubborn obsessive-compulsive disorder, experts sometimes push doses past the guidelines, Mario Pinzi and colleagues document in a 2026 paper. A review of past evidence sits beside five hard cases from a referral clinic. Each patient had failed at least two full serotonin drug trials, clomipramine included, plus talk therapy where it was offered.
Five push-harder routes appear: very high SSRI doses, mirtazapine added to an SSRI, two SSRIs at once, extra serotonin drugs beside clozapine, and topiramate. Scores fell by twenty-three to thirty-six percent in twelve weeks, with one full response and no serotonin poisoning. The authors limit such moves to expert centers with close checks.
Catalog record
| CREATOR | Mario Pinzi, Alessandro Cuomo, Pietro Carmellini, Claudia Libri, Maria B. Rescalli, Caterina Pierini, Alessia Santangelo, Benjamin Patrizio, Andrea Fagiolini |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 59827 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |